Titre : Conotoxines

Conotoxines : Questions médicales fréquentes

Termes MeSH sélectionnés :

Common Variable Immunodeficiency
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Conotoxines : Questions médicales les plus fréquentes", "headline": "Conotoxines : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Conotoxines : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-05-20", "dateModified": "2025-02-14", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Conotoxines" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Venins de mollusque", "url": "https://questionsmedicales.fr/mesh/D008978", "about": { "@type": "MedicalCondition", "name": "Venins de mollusque", "code": { "@type": "MedicalCode", "code": "D008978", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D23.946.833.590" } } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Conotoxines-oméga", "alternateName": "omega-Conotoxins", "url": "https://questionsmedicales.fr/mesh/D020960", "about": { "@type": "MedicalCondition", "name": "Conotoxines-oméga", "code": { "@type": "MedicalCode", "code": "D020960", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D23.946.833.590.162.720" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Conotoxine-oméga-GVIA", "alternateName": "omega-Conotoxin GVIA", "url": "https://questionsmedicales.fr/mesh/D020866", "about": { "@type": "MedicalCondition", "name": "Conotoxine-oméga-GVIA", "code": { "@type": "MedicalCode", "code": "D020866", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D23.946.833.590.162.720.700" } } } ] } ], "about": { "@type": "MedicalCondition", "name": "Conotoxines", "alternateName": "Conotoxins", "code": { "@type": "MedicalCode", "code": "D020916", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Sulan Luo", "url": "https://questionsmedicales.fr/author/Sulan%20Luo", "affiliation": { "@type": "Organization", "name": "Key Laboratory of Tropical Biological Resources of Ministry of Education, Key Lab for Marine Drugs of Haikou, School of Life and Pharmaceutical Sciences, Hainan University, Haikou, Hainan, China." } }, { "@type": "Person", "name": "Dongting Zhangsun", "url": "https://questionsmedicales.fr/author/Dongting%20Zhangsun", "affiliation": { "@type": "Organization", "name": "Key Laboratory of Tropical Biological Resources of Ministry of Education, Key Lab for Marine Drugs of Haikou, School of Life and Pharmaceutical Sciences, Hainan University, Haikou, Hainan, China." } }, { "@type": "Person", "name": "Richard J Lewis", "url": "https://questionsmedicales.fr/author/Richard%20J%20Lewis", "affiliation": { "@type": "Organization", "name": "Institute for Molecular Bioscience , The University of Queensland , Brisbane Queensland 4072 , Australia." } }, { "@type": "Person", "name": "Xiaopeng Zhu", "url": "https://questionsmedicales.fr/author/Xiaopeng%20Zhu", "affiliation": { "@type": "Organization", "name": "Key Laboratory of Tropical Biological Resources of Ministry of Education, Key Laboratory for Marine Drugs of Haikou, School of Life and Pharmaceutical Sciences, Hainan University, Haikou 570228, China." } }, { "@type": "Person", "name": "David J Adams", "url": "https://questionsmedicales.fr/author/David%20J%20Adams", "affiliation": { "@type": "Organization", "name": "Illawarra Health and Medical Research Institute, University of Wollongong, Wollongong, Australia (A.R.B., J.R.M., D.J.A.); School of Science, RMIT University, Melbourne, Australia (A.K., A.H.); and School of Health and Biomedical Sciences, RMIT University, Bundoora, Australia (A.R.W) djadams@uow.edu.au andrew.hung@rmit.edu.au." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "B- and T-Cell Subset Abnormalities in Monogenic Common Variable Immunodeficiency.", "datePublished": "2022-06-15", "url": "https://questionsmedicales.fr/article/35784324", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.3389/fimmu.2022.912826" } }, { "@type": "ScholarlyArticle", "name": "Norovirus infection as a model of chronic or recurrent infection in common variable immunodeficiency.", "datePublished": "2022-10-24", "url": "https://questionsmedicales.fr/article/36285861", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.37201/req/s03.14.2022" } }, { "@type": "ScholarlyArticle", "name": "Autoimmune disorders associated with common variable immunodeficiency: prediction, diagnosis, and treatment.", "datePublished": "2022-10-17", "url": "https://questionsmedicales.fr/article/36197300", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1080/1744666X.2022.2132938" } }, { "@type": "ScholarlyArticle", "name": "Evaluating Drug Prescription Patterns in Undiagnosed Common Variable Immunodeficiency Patients.", "datePublished": "2023-10-14", "url": "https://questionsmedicales.fr/article/37833619", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1007/s10875-023-01598-1" } }, { "@type": "ScholarlyArticle", "name": "Adipokines from adipose tissue and common variable immunodeficiency: Is there any association?", "datePublished": "2023-06-05", "url": "https://questionsmedicales.fr/article/37873571", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1111/sji.13257" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Facteurs biologiques", "item": "https://questionsmedicales.fr/mesh/D001685" }, { "@type": "ListItem", "position": 3, "name": "Toxines biologiques", "item": "https://questionsmedicales.fr/mesh/D014118" }, { "@type": "ListItem", "position": 4, "name": "Venins", "item": "https://questionsmedicales.fr/mesh/D014688" }, { "@type": "ListItem", "position": 5, "name": "Venins de mollusque", "item": "https://questionsmedicales.fr/mesh/D008978" }, { "@type": "ListItem", "position": 6, "name": "Conotoxines", "item": "https://questionsmedicales.fr/mesh/D020916" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Conotoxines - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Conotoxines", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-01", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Conotoxines", "description": "Comment diagnostiquer une intoxication par conotoxines ?\nQuels tests sont utilisés pour détecter les conotoxines ?\nQuels symptômes indiquent une intoxication par conotoxines ?\nLes conotoxines sont-elles détectables dans le sang ?\nY a-t-il des marqueurs biologiques pour les conotoxines ?", "url": "https://questionsmedicales.fr/mesh/D020916?mesh_terms=Common+Variable+Immunodeficiency&page=3#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Conotoxines", "description": "Quels sont les symptômes courants des conotoxines ?\nLes conotoxines provoquent-elles des troubles respiratoires ?\nPeut-on ressentir des douleurs après exposition aux conotoxines ?\nLes symptômes des conotoxines sont-ils immédiats ?\nY a-t-il des symptômes neurologiques associés aux conotoxines ?", "url": "https://questionsmedicales.fr/mesh/D020916?mesh_terms=Common+Variable+Immunodeficiency&page=3#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Conotoxines", "description": "Comment prévenir l'exposition aux conotoxines ?\nY a-t-il des mesures de sécurité pour les plongeurs ?\nLes conotoxines peuvent-elles être évitées par la cuisson ?\nLes enfants sont-ils plus à risque d'exposition ?\nDes campagnes de sensibilisation existent-elles ?", "url": "https://questionsmedicales.fr/mesh/D020916?mesh_terms=Common+Variable+Immunodeficiency&page=3#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Conotoxines", "description": "Quel est le traitement principal pour l'intoxication par conotoxines ?\nDes antidotes existent-ils pour les conotoxines ?\nComment gérer la douleur causée par les conotoxines ?\nLes soins intensifs sont-ils nécessaires pour les cas graves ?\nPeut-on utiliser des médicaments pour traiter les symptômes ?", "url": "https://questionsmedicales.fr/mesh/D020916?mesh_terms=Common+Variable+Immunodeficiency&page=3#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Conotoxines", "description": "Quelles complications peuvent survenir après une intoxication ?\nLes complications sont-elles réversibles ?\nY a-t-il un risque de décès lié aux conotoxines ?\nLes complications nécessitent-elles un suivi médical ?\nLes complications peuvent-elles affecter la qualité de vie ?", "url": "https://questionsmedicales.fr/mesh/D020916?mesh_terms=Common+Variable+Immunodeficiency&page=3#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Conotoxines", "description": "Qui est le plus à risque d'intoxication par conotoxines ?\nLes personnes allergiques sont-elles plus vulnérables ?\nL'âge influence-t-il le risque d'intoxication ?\nLes personnes avec des antécédents médicaux sont-elles plus à risque ?\nLes régions géographiques influencent-elles le risque ?", "url": "https://questionsmedicales.fr/mesh/D020916?mesh_terms=Common+Variable+Immunodeficiency&page=3#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment diagnostiquer une intoxication par conotoxines ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Le diagnostic repose sur l'historique d'exposition et les symptômes cliniques." } }, { "@type": "Question", "name": "Quels tests sont utilisés pour détecter les conotoxines ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Des tests biologiques et des analyses de sang peuvent être effectués." } }, { "@type": "Question", "name": "Quels symptômes indiquent une intoxication par conotoxines ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Les symptômes incluent paralysie, douleur intense et troubles respiratoires." } }, { "@type": "Question", "name": "Les conotoxines sont-elles détectables dans le sang ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des méthodes spécifiques peuvent détecter les conotoxines dans le sang." } }, { "@type": "Question", "name": "Y a-t-il des marqueurs biologiques pour les conotoxines ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "Actuellement, il n'existe pas de marqueurs spécifiques pour les conotoxines." } }, { "@type": "Question", "name": "Quels sont les symptômes courants des conotoxines ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Les symptômes incluent des douleurs, des nausées, et des troubles neurologiques." } }, { "@type": "Question", "name": "Les conotoxines provoquent-elles des troubles respiratoires ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Oui, elles peuvent entraîner des difficultés respiratoires graves." } }, { "@type": "Question", "name": "Peut-on ressentir des douleurs après exposition aux conotoxines ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des douleurs aiguës et localisées sont fréquentes après exposition." } }, { "@type": "Question", "name": "Les symptômes des conotoxines sont-ils immédiats ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Les symptômes peuvent apparaître rapidement, souvent en quelques minutes." } }, { "@type": "Question", "name": "Y a-t-il des symptômes neurologiques associés aux conotoxines ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des symptômes comme la paralysie et des troubles de la coordination peuvent survenir." } }, { "@type": "Question", "name": "Comment prévenir l'exposition aux conotoxines ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "Évitez de manipuler les cônes marins et portez des gants lors de la pêche." } }, { "@type": "Question", "name": "Y a-t-il des mesures de sécurité pour les plongeurs ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les plongeurs doivent être formés aux risques liés aux cônes marins." } }, { "@type": "Question", "name": "Les conotoxines peuvent-elles être évitées par la cuisson ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "La cuisson ne neutralise pas les conotoxines, il faut éviter leur consommation." } }, { "@type": "Question", "name": "Les enfants sont-ils plus à risque d'exposition ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les enfants peuvent être plus vulnérables en raison de leur curiosité." } }, { "@type": "Question", "name": "Des campagnes de sensibilisation existent-elles ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des campagnes sensibilisent le public aux dangers des cônes marins." } }, { "@type": "Question", "name": "Quel est le traitement principal pour l'intoxication par conotoxines ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Le traitement est symptomatique et peut inclure des soins de soutien en milieu hospitalier." } }, { "@type": "Question", "name": "Des antidotes existent-ils pour les conotoxines ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "Actuellement, il n'existe pas d'antidote spécifique pour les conotoxines." } }, { "@type": "Question", "name": "Comment gérer la douleur causée par les conotoxines ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "Des analgésiques et des traitements symptomatiques sont utilisés pour gérer la douleur." } }, { "@type": "Question", "name": "Les soins intensifs sont-ils nécessaires pour les cas graves ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les cas graves peuvent nécessiter des soins intensifs pour surveiller la respiration." } }, { "@type": "Question", "name": "Peut-on utiliser des médicaments pour traiter les symptômes ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des médicaments peuvent être administrés pour traiter les symptômes spécifiques." } }, { "@type": "Question", "name": "Quelles complications peuvent survenir après une intoxication ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Des complications neurologiques et respiratoires peuvent survenir après l'exposition." } }, { "@type": "Question", "name": "Les complications sont-elles réversibles ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Certaines complications peuvent être réversibles, mais d'autres peuvent être permanentes." } }, { "@type": "Question", "name": "Y a-t-il un risque de décès lié aux conotoxines ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "Oui, une intoxication sévère peut entraîner un risque de décès par paralysie respiratoire." } }, { "@type": "Question", "name": "Les complications nécessitent-elles un suivi médical ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Oui, un suivi médical est souvent nécessaire pour évaluer les complications." } }, { "@type": "Question", "name": "Les complications peuvent-elles affecter la qualité de vie ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les complications peuvent avoir un impact significatif sur la qualité de vie." } }, { "@type": "Question", "name": "Qui est le plus à risque d'intoxication par conotoxines ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "Les plongeurs, pêcheurs et personnes manipulant des cônes marins sont à risque." } }, { "@type": "Question", "name": "Les personnes allergiques sont-elles plus vulnérables ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les personnes allergiques peuvent avoir des réactions plus sévères aux conotoxines." } }, { "@type": "Question", "name": "L'âge influence-t-il le risque d'intoxication ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les jeunes enfants et les personnes âgées sont plus à risque." } }, { "@type": "Question", "name": "Les personnes avec des antécédents médicaux sont-elles plus à risque ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les personnes avec des antécédents neurologiques peuvent être plus vulnérables." } }, { "@type": "Question", "name": "Les régions géographiques influencent-elles le risque ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le risque est plus élevé dans les régions côtières où vivent les cônes marins." } } ] } ] }

Sources (10000 au total)

Autoimmune disorders associated with common variable immunodeficiency: prediction, diagnosis, and treatment.

Common variable immunodeficiency (CVID) is the most common symptomatic primary immunodeficiency. Due to the wide spectrum of the CVID manifestations, the differential diagnosis becomes complicated, en... In this article, genetics, responsible immune defects, autoimmune manifestations in different organs, and the diagnosis and treatment processes in CVID patients are reviewed, after searching the liter... Considering the many phenotypes of CVID and the fact that it remained undiagnosed until older ages, it is important to include various manifestations of CVID in the differential diagnosis. Due to the ...

Evaluating Drug Prescription Patterns in Undiagnosed Common Variable Immunodeficiency Patients.

To compare the consumption of antibiotics (AB), systemic steroids, and inhaled bronchodilators/glucocorticoids in the 3 years preceding the diagnosis of common variable immunodeficiency (CVID) among C... We conducted a nested case-control study, identifying all individuals (n=130 cases) diagnosed with CVID in Denmark (1994-2014) and 45 age- and sex-matched population controls per case (n=5850 controls... In the 3 years preceding a CVID diagnosis, we observed more frequent and higher consumption of all three drug classes. The association between consumption and risk of subsequent CVID diagnosis was sta... CVID patients have significantly higher use of AB, systemic steroids, and inhaled bronchodilators/glucocorticoids in the 3 years preceding CVID diagnosis than controls. Prescribing these drugs in prim...

Lymphocyte alterations in patients with Common Variable Immunodeficiency (CVID) and autoimmune manifestations.

Autoimmunity is a common feature in CVID patients. To date the mechanisms leading to the development of such complications are not fully elucidated.... Data from 122 CVID patients subdivided in three groups based on the absence of autoimmunity (n-AI) or the presence of hematologic autoimmune phenomena (Cy-AI) or non-hematologic autoimmune phenomena (... We identified a total of 128 autoimmune manifestations in 55/122 patients (45.1%). 30/122 (24.6%) patients presented hematologic autoimmune phenomena while 29/122 (23.8%) presented gastrointestinal au... CVID patients developing autoimmune cytopenias display characteristic immune phenotypic features....

Application of the diagnostic criteria for Common Variable Immunodeficiency in resource-limited settings.

Common variable immunodeficiency (CVID) is the most prevalent symptomatic humoral deficiency; however, its heterogeneous presentation makes the diagnosis difficult. The present study is aimed to verif... Information was collected from their medical records and when needed, lymphocyte subpopulations in peripheral blood (PB) were performed by flow cytometry.... All the patients fulfilled the clinical working definition for CVID and showed decreased serum IgG and IgA at diagnosis. Over two-thirds of the patients had decreased memory B cell percentages. Howeve... Further efforts are needed to speed up CVID diagnosis in low-resourced settings, increasing the availability of the required resources and optimizing the healthcare supply chain....

Fecal microbiota transplantation in a patient with chronic diarrhea and primary and secondary immunodeficiency (common variable immunodeficiency and splenectomy).

The gut microbiota serves a crucial role in the development of host immunity. Immunocompromised patients are particularly vulnerable to dysbiosis not only by virtue of a defect in the immune system bu...